12th May 2020 Subject: Management Discussion and Analysis for the three-month period ending 31st March 2020. Attention: President Stock Exchange of Thailand Please find below the additional
Our Ref: APURE 033/2020 13 November 2020 Subject Clarification on 3rd Quarter’s Operating Performance (3/2020) Attn. To President The Stock Exchange of Thailand The company clarifies causes and
Our Ref: APURE 019/2023 12 May 2023 Subject Clarification on First Quarter’s Operating Performance (1/2023) Attn. To The Director and President of the Stock Exchange of Thailand The company clarifies
Page 1 of 2 ACC6711/003 November 14, 2024 Subject: Clarification of operating results for the third quarter of 2024 ended September 30, 2024 Dear Directors and Managers Stock Exchange of Thailand
capital increase proposal for private placement, feasibility and objective for company?s interest including appropriateness of placement method, placement price and price determination as well as share
referral from the Stock Exchange of Thailand, the SEC probed into the case and found that on September 16, 2013, {A} had traded 130.12 million SSI shares by placing a total of 299 trading orders through
Microsoft Word - MD&A 2Q17 EN August 15, 2017 To President, The Stock Exchange of Thailand Subject Notification on the difference of revenue from sales and net profit YOY by more than 20 percent
(Translation) UAC.CS/014/2017 November 13, 2017 Subject: Explanation of the operating results for the third quarter period ended September 30, 2017 To: President The Stock Exchange of Thailand
Microsoft Word - 2017 Results Notification letter_English February 13, 2018 The Director and Manager The Stock Exchange of Thailand Re: Information concerning Fiscal Year 2017 Operating Results KCE
. DOD017/2562 May 8, 2019 Re: Management’s Discussion and Analysis (MD&A) of the Consolidated Financial Results for Quarter 1 of 2019 To: The President The Stock Exchange of Thailand DOD Biotech Public